SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-031619
Filing Date
2023-07-05
Accepted
2023-07-05 16:05:55
Documents
12
Period of Report
2023-06-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K dvax-20230630.htm   iXBRL 8-K 70539
  Complete submission text file 0000950170-23-031619.txt   185317

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dvax-20230630_lab.xml EX-101.LAB 12806
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dvax-20230630_pre.xml EX-101.PRE 9451
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dvax-20230630.xsd EX-101.SCH 2466
6 EXTRACTED XBRL INSTANCE DOCUMENT dvax-20230630_htm.xml XML 4534
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34207 | Film No.: 231068804
SIC: 2834 Pharmaceutical Preparations